Ligand Pharmaceuticals market cap LGND

Share price times shares outstanding: what the whole company sells for, since 2011.

Ligand Pharmaceuticals is worth $6.1B at the close on Oct 23, 2026, at $303.53 a share.

That is up 65% over the last year and up 299% over five years.

Its highest close in our data was $6.4B in Jul 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$6.1B	$3.6B	$6.4B	+57%
2025	$3.9B	$1.9B	$4B	+87%
2024	$2.1B	$1.2B	$2.4B	+66%
2023	$1.2B	$860.3M	$1.4B	+10%
2022	$1.1B	$816.6M	$1.5B	−30%
2021	$1.6B	$1.1B	$2B	+61%
2020	$998.3M	$687.8M	$1.2B	−15%
2019	$1.2B	$1B	$1.8B	−35%
2018	$1.8B	$1.8B	$3.6B	−0%
2017	$1.8B	$1.3B	$1.9B	+36%
2016	$1.3B	$1.1B	$1.8B	−2%
2015	$1.3B	$658.5M	$1.4B	+108%
2014	$649.1M	$576M	$979.5M	−6%
2013	$688.6M	$241.4M	$726.9M	+169%
2012	$256.1M	$142.2M	$265.7M	+76%
2011	$145.6M	$134.6M	$192.6M	n/a

Companies in Drug Manufacturers - General nearest Ligand Pharmaceuticals' size, closest first, today.

Company	Market cap
LGNDLigand Pharmaceuticals	$6.1B
KNSAKiniksa Pharmaceuticals International	$6B
AMRXAmneal Pharmaceuticals	$6.5B
ALKSAlkermes plc.	$7.3B
TGTXTG Therapeutics	$8.3B
PTGXProtagonist Therapeutics	$9B
INDVIndivior Pharmaceuticals	$4.1B
CORTCorcept Therapeutics	$9.3B
ARQTArcutis Biotherapeutics	$3.9B
LQDALiquidia	$3.8B
OGNOrganon	$3.6B
Peer median	$6.2B